Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)
Clinical trial NCT02331251 · TERMINATED
Trial details
- NCT number
- NCT02331251
- Sponsor
- Western Regional Medical Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2018-01-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.